Camurus, Eli Lilly Collaborate for Long-Acting Incretin Products Using FluidCrystal Technology

On Tuesday, Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement.

Keep Reading →